Literature DB >> 2052502

Motilin receptors of the rabbit colon.

I Depoortere1, T L Peeters, G Vantrappen.   

Abstract

Binding studies with iodinated motilin revealed that in the small intestine motilin receptor density decreased aborally, disappeared in the caecum but returned in the colon and rectum. The highest density was in the distal colon (112 +/-/11 fmol/mg protein). The dissociation constant was the same in all regions (overall mean 1.10 +/- 0.22 nM). The ability of erythromycin-A (EM-A) and of two derivatives, EM-A N-oxide and EM-523, to displace motilin showed no difference between the tissues studied. Their order of potency was: motilin greater than EM-523 greater than EM-A greater than EM-A N-oxide. Proximal circular colonic smooth muscle strips showed maximal contractile responses towards motilin, EM-523 and EM-A of, respectively, 80 +/- 3%, 78 +/- 4% and 84 +/- 2% relative to the maximum obtained with acetylcholine. In proximal longitudinal muscle only a response of +/- 20% was obtained. Similar responses were obtained in the distal colon. The order of potency to induce contractions as reflected in the pED50 values was: motilin (8.03 +/- 0.1) greater than EM-523 (7.55 +/- 0.03) greater than EM-A (5.84 +/- 0.04) in proximal circular colon. The responses were not blocked by TTX (10(-6) M) or atropine (10(-6) M), but were reduced by verapamil (10(-6)M). The abundance of motilin receptors in colonic smooth muscle, if applicable to other species, opens new perspectives for the therapeutic applications of macrolides with motilin agonist properties.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052502     DOI: 10.1016/0196-9781(91)90172-l

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

Review 1.  Growth hormone secretagogue receptor family members and ligands.

Authors:  R G Smith; R Leonard; A R Bailey; O Palyha; S Feighner; C Tan; K K Mckee; S S Pong; P Griffin; A Howard
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

Review 2.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Stimulating action of KW-5139 (Leu13-motilin) on gastrointestinal motility in the rabbit.

Authors:  T Kitazawa; S Ichikawa; T Yokoyama; A Ishii; K Shuto
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

4.  Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro.

Authors:  Kenji Yogo; Ken-Ichi Ozaki; Hisanori Takanashi; Masao Koto; Zen Itoh; Satoshi Omura
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

5.  Effect of oral erythromycin on colonic transit in patients with idiopathic constipation. A pilot study.

Authors:  S S Sharma; N Bhargava; S C Mathur
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

Review 6.  Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.

Authors:  Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Erythromycin and motilin stimulate sphincter of Oddi motility and inhibit trans-sphincteric flow in the Australian possum.

Authors:  G T Saccone; Y F Liu; A Thune; J R Harvey; R A Baker; J Toouli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

Review 8.  Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility.

Authors:  Takio Kitazawa; Hiroyuki Kaiya
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-23       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.